Navigation Links
Signalife Announces AFL Joins NIH Education Program
Date:6/17/2008

LOS ANGELES, June 17 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) and Athletes for Life Foundation announced that the Athletes for Life Foundation will conduct heart monitoring and screening at the Pontotoc Technology Center in Ada, Oklahoma. Willie Gault, Olympic gold medalist, Super Bowl champion, and a founder of the Athletes for Life Foundation, will be present on June 24-25th to participate in a children's health education program sponsored by the National Library of Medicine (NLM), a division of the National Institute of Health's (NIH).

The Athletes for Life Foundation has selected Signalife's award winning technology to perform heart monitoring and screening as part of the program's activities. The Signalife monitor is a 12 lead ambulatory ECG device capable of detecting subtle ECG changes that may be significant for early diagnosis of potential heart problems.

The Athletes for Life Foundation's co-founder, Willie Gault, commented: "I cannot begin to put into words how grateful I am to the NIH for inviting me to join their efforts in educating children. The foundation is bringing Signalife's heart monitoring and screening to the public, for free, as part of its continued effort to shift the healthcare balance from costly reactive heart disease treatments to early heart disease detection. A number of high profile sports and media personalities have recently passed away from heart disease. Perhaps use of this technology would have allowed life saving intervention. The foundation believes that providing annual heart screening for all people, before symptoms are apparent, can have an enormous impact in our efforts to save lives and lower the cost of healthcare throughout the world. We are thankful to all those who have supported our efforts to 'save lives, one heart at a time'."

About Athletes for Life Foundation

The Athletes for Life Foundation, http://www.athletes
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
2. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
3. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
4. Signalife Announces Webcast
5. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
6. Signalife Sees Accretive Purchase and Financial Commitments
7. Signalife Wins Second Frost & Sullivan Technology Award
8. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
9. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. U.S. Patent 7,299,083 Awarded to Signalife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... The winners of awards for supply chain ... Global Supply Chain Resiliency Council (GSCRC) at ... February 25th, 2015, at the Hyatt Regency in Santa ... together supply chain risk management and resiliency practitioners with ... through opportunities to collaborate, develop and share best practices, ...
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... 2015  Rosa & Co. LLC, a drug development ... research, today announced it has two posters scheduled to ... Pharmacology and Therapeutics meeting in New Orleans, ... Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   Bristol- ... describing a quantitative systems pharmacology approach for immuno-oncology drug ...
(Date:3/3/2015)... FRANCISCO , March 3, 2015 Kindred Biosciences, ... on saving and improving the lives of pets, announced today ... financial results on March 12, 2015 after the market close. ... Eastern Time that day. Interested parties may ... US, or (484) 756-4262 internationally, and using conference ID 98449349.  ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
... R-Tech Ueno, Ltd. announced on July 29 after discussing its R&D ... the day and determined the R&D items as follows. , ... the ophthalmologic & dermatological fields that are its priority and exclusive ... , 1. Development code UF-021 (eye diseases) , ...
... , , SAN DIEGO, July 30 ... the protocol for the Company,s Phase II trial of ANA598 in combination ... the protocol has been received from the United States Food and Drug ... several weeks. , , In the Phase II study, ...
... , , SEATTLE, July 30 Trubion ... to issue earnings results for its second quarter and six months ended ... The company,s earnings conference call will take place Aug. 6, 2009 at ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , , The ...
Cached Biology Technology:R-Tech Ueno Notifies R&D Items 2R-Tech Ueno Notifies R&D Items 3Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 2Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 3Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 4Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients 5Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 2
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... flowers have evolved particular colours, shapes and scents ... using artificial flowers and high-speed video, researchers have ... hummingbirds and the flowers they pollinate. The study, ... Functional Ecology , is the first to measure ...
... grey seal mums adopt risky tactics when it comes to the ... a real advantage, according to scientists. Researchers from Durham University, ... colonies in Scotland, found that some seal mothers are flexible in ... their actions, whilst other play it safe and steady. ...
... Calif.) When your neighbor asks to borrow a cup of ... of the give and take that characterize your longstanding relationship? Or ... of sugar you borrowed last week, or may need to borrow ... anthropology at UC Santa Barbara, and a junior research fellow at ...
Cached Biology News:High-speed video and artificial flowers shed light on mysteries of hummingbird-pollinated flowers 2Seals gamble with their pups' futures 2Seals gamble with their pups' futures 3UCSB anthropologist studies reciprocity among chimpanzees and bonobos 2UCSB anthropologist studies reciprocity among chimpanzees and bonobos 3
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
Fetal Calf Serum Replacement (Bistec) serum...
...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
Biology Products: